Clinical trial · Interventional
Optimize the Requirements and Preparations in Outpatient Chemotherapy
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A prescription of injectable anticancer therapy requires the collection of medical data (interview and physical examination) and often allied (laboratory tests). This requirement is made on the day of the arrival of the patient to not prepare these treatments incorrectly. After receiving the prescription of treatment, it will take about 1 hour to prepare for pharmacy and more in times of high activity, to provide the day hospital pockets treatment, incompressible time when the patient waits to have his treatment. A process has been selected (Optima) to anticipate prescribing injectable cancer treatments and their manufacturing to reduce patient waiting times on the day of his coming François BaclesseCentre day hospital.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| IV Anticancer Therapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Paramedic telephone consultation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Paramedic telephone consultation
- description
- Establishment of a paramedic telephone consultation to the doctor to record the "virtual" early prescription or non-injectable cancer treatment before the arrival of the patient (Feasibility Process Optima), without changing the current practice of prescribing and dispensing of these treatments on the day of the coming of the patient.
- interventionNames
- Other: Paramedic telephone consultation
Primary outcomes (1)
- measure
- Patient profile for Optima
- timeFrame
- up to 21 weeks
- description
- Rate of discordance for each chemotherapy protocol between the Optima process and the current process. Define which protocols for injectable cancer treatment (chemotherapy and / or targeted therapy) and for which patient profiles, the Optima process can be used routinely.
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patient (e) old (e) 18 or more; * Patient (e) reached (e) from cancer and candidate (s) to treatment with injectable anticancer preparations in day hospital * solid cancerous disease for which chemotherapy is given intravenously; * Patient (e) able to communicate with the investigator or his representative; * Patient (e) Affiliate (e) a social security scheme; * Mastery of the French language; * Consent and signed. Exclusion Criteria: * Exclusive orallyanticancer treatment ; * Primary brain tumors; * Patient (e) dysphonic or having difficulty communicating orally; * Patient (e) receiving intravenous chemotherapy as part of a research protocol; * Patient (e) to receive chemotherapy whose stability is less than 24:00 (Temsirolimus) * Pathologies hematologic malignancies * Inability to undergo medical monitoring test for geographical, social or psychological reasons. * Patient (e) under guardianship or unable to give informed consent; * Patient (s) whose cognitive functions do not allow a telephone interview. * Any medical or psychological condition associated that could compromise the patient's ability to participate in the study
References
Publications (0)
Data not yet available